Wex Pharmaceuticals Incorporation (WXI) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Wex Pharmaceuticals Incorporation Company Snapshot

Business Description:

Wex Pharmaceuticals Incorporation operates in the Pharmaceutical preparations sector. WEX Pharmaceuticals Inc. is a Canada-based company engaged in the discovery, development, manufacture and marketing of drug products for pain management. The Company's platform technology is built upon tetrodotoxin (TTX), a naturally occurring sodium channel blocking compound found primarily in the puffer fish or blowfish. The Company's products based on TTX are: Tectin, which is being developed as a medication intended to provide relief for various chronic pain conditions associated with cancer; Tetrodin a non-narcotic pharmaceutical, with potent analgesic properties; Tocudin, which is an offer for patients undergoing surgery or procedures for which general anesthesia may be impractical or unnecessary. The Company operates through two subsidiaries located in Hong-Kong and Nanning, China.

Stock Performance Chart for Wex Pharmaceuticals Incorporation

Stock Data:

Recent Stock Performance:

Current Price (4/28/2011): .14
(Figures in Canadian Dollars)

1 Week	12.5%	13 Weeks	3.8%

4 Weeks	-6.9%	52 Weeks	-10.0%

Wex Pharmaceuticals Incorporation Key Data:

Ticker:	WXI	Country:	CANADA

Exchanges:	MON TOR	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2008 Sales	1,001,768 (Year Ending Jan 2009).	Employees:	13

Currency:	Canadian Dollars	Market Cap:	N/A

Fiscal Yr Ends:	December	Shares Outstanding:	N/A

Share Type:	Common	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.